Pot stocks gain as global markets sink on coronavirus fears

Over 2 million people in the U.S. are estimated to have lost their jobs due to COVID-19

As the Dow Jones Industrial Average and the S&P 500 erased all of its gains since President Donald Trump took office in January of 2017, pot stocks were on the rise early in the session on Monday.

Cannabis companies Tilray, Hexo, Canopy Growth and Aphria kicked off Monday’s session in the green despite the coronavirus outbreak, which has left markets reeling in recent weeks.

COVID-19, which has infected over 350,000 people worldwide as of Monday morning, while those numbers could go even higher as monetary policy and stimulus measures fail to soothe markets.

However, increased demand for cannabis appears to be driving pot stocks higher, particularly as dispensaries in California and several other U.S. states were declared “essential” businesses, paving the way for uninterrupted operations during lockdowns introduced in a number of counties.

According to one analyst at Bank of America, pot sales are booming across the U.S.

“Our checks across North America were consistent: regardless of region, cannabis purchases have accelerated. While likely on pantry loading, it’s not unreasonable to think there will be some boost to per capita consumption as people stay at home longer,” Christopher Carey said in a note, as reported by BNN Bloomberg.

Green Market Report CEO Debra Borchardt agrees. The executive told Benzinga that cannabis companies are better adapted to changing circumstances which caught other businesses off guard.

Read the full article at GREENCAMP